Pergoveris clinical trials
How each study uses pergoveris is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Pergoveris
- 5
Studies by the year they started
5 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 3
Merck KGaA, Darmstadt, Germany (2) · Vietnam National University (1) · Centro Riproduzione e Andrologia (1) · Nova Clinic, Russia (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses pergoveris is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- PERgoveriS In Stratified Treatment for Assisted Reproductive TechniqueCompletedPhase 3Merck KGaA, Darmstadt, GermanyNCT01297465Written as Pergoveris®
- Double Ovarian Stimulation as Accumulation Strategy for Older Infertile Patients With Suboptimal Ovarian ResponseStatus unknownPhase 4Nova Clinic, RussiaNCT03400722Written as Pergoveris
- Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)CompletedPhase 3Merck KGaA, Darmstadt, GermanyNCT02047227Written as Pergoveris®
- Efficacy of Pergoveris in Aged IVF PatientsCompletedNot applicableVietnam National UniversityNCT02244866Written as Pergoveris (FSH and LH)
- Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HPCompletedNot applicableCentro Riproduzione e AndrologiaNCT01623570Written as Pergoveris: 150IU r-hFSH + 75IU r-hLH